Final results of NKTR-102, a topoisomerase I inhibitor-polymer conjugate, in patients (Pts) with pretreated metastatic breast cancer (MBC) demonstrating significant antitumor activity.
A. Garcia
No relevant relationships to disclose
A. Awada
No relevant relationships to disclose
S. Chan
No relevant relationships to disclose
G. H. M. Jerusalem
No relevant relationships to disclose
R. E. Coleman
No relevant relationships to disclose
M. T. Huizing
No relevant relationships to disclose
A. Mehdi
No relevant relationships to disclose
S. M. O'Reilly
No relevant relationships to disclose
J. T. Hamm
No relevant relationships to disclose
P. J. Barrett-Lee
No relevant relationships to disclose
V. Cocquyt
No relevant relationships to disclose
K. Sideras
No relevant relationships to disclose
D. E. Young
No relevant relationships to disclose
M. Brown
Employment or Leadership Position - Nektar
C. Zhao
Employment or Leadership Position - Nektar
A. L. Hannah
Consultant or Advisory Role - Nektar
A. C. F. Leung
Employment or Leadership Position - Nektar
L. K. Masuoka
Employment or Leadership Position - Nektar
E. A. Perez
No relevant relationships to disclose